In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has submitted a copy of the published extract of unaudited consolidated financial results for the for the quarter ended 30th June 2024 along with information on standalone financial results. The same was published on Saturday, 3rd August 2024 in the Ahmedabad edition of Financial Express (English) and Financial Express (Gujarati).
The above information is a part of company’s filings submitted to BSE.
